{"brief_title": "A Study of Motexafin Gadolinium for the Treatment of Relapsed or Refractory Multiple Myeloma", "brief_summary": "The purpose of the study is to determine if the drug motexafin gadolinium will be an effective treatment for patients who have relapsed or refractory multiple myeloma.", "condition": "Multiple Myeloma", "intervention_type": "Drug", "intervention_name": "Motexafin Gadolinium Injection", "criteria": "Inclusion Criteria: - Relapsed or Refractory Multiple Myeloma - \u2265 18 years old - Able to provide consent for participation - ECOG status 0-2 Lab values: - ANC \u2265 1,000/\u00b5L - WBC count \u2265 2.0/\u00b5L - Hemoglobin \u2265 8.0 g/dL - Platelet count \u2265 50,000/\u00b5L - AST and ALT \u2264 2 x ULN - Total Bilirubin \u2264 2 x ULN - Creatinine \u2264 2.0 mg/dL and - Not pregnant or lactating", "gender": "All", "minimum_age": "18 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "id": "NCT00096837.xml"}